Ernest Loumaye
Founder en OBSEVA SA .
Fortuna: 144 300 $ al 31/03/2024
Perfil
Ernest Loumaye was the founder of PregLem SA, a company founded in 2006, where he held the title of Chief Executive Officer from 2011 to 2012.
He is also the founder of ObsEva SA, a company founded in 2012, where he currently holds the title of Chairman.
In addition to his founding positions, Dr. Loumaye has held former jobs at Calliditas Therapeutics Suisse SA, where he served as Chairman from 2011 to 2016, and at Ava AG, where he was a Director from 2019 to 2021.
He also held positions at Ipsen SA as Vice President-Medical Sciences and at Serono SA as Head-Clinical Development.
Dr. Loumaye obtained his undergraduate and doctorate degrees from Université Catholique de Louvain.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
OBSEVA SA
6.81% | 17/04/2023 | 10 000 000 ( 6.81% ) | 144 300 $ | 31/03/2024 |
Cargos activos de Ernest Loumaye
Empresas | Cargo | Inicio |
---|---|---|
OBSEVA SA | Founder | 14/11/2012 |
Antiguos cargos conocidos de Ernest Loumaye.
Empresas | Cargo | Fin |
---|---|---|
Ava AG
Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Director/Board Member | 01/01/2021 |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Chairman | 01/01/2016 |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Chief Executive Officer | 01/10/2012 |
IPSEN | Corporate Officer/Principal | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - |
Formación de Ernest Loumaye.
Université Catholique de Louvain | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
IPSEN | Health Technology |
OBSEVA SA | Health Technology |
Empresas privadas | 4 |
---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Ava AG
Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Ernest Loumaye